Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 998Sesión 2026

Qué cambió entre versiones

31 párrafos cambiaron+286 palabras agregadas−422 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

2026 SESSION

HOUSE SUBSTITUTE

INTRODUCED

26106498D26104843D

HOUSE BILL NO. 998

FLOOR AMENDMENT IN THE NATURE OF A SUBSTITUTE

(Patron Prior to Substitute—Delegate Seibold)

Offered January 14, 2026

Prefiled January 14, 2026

A BILL to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1, relating to menstrual supplies ingredient labeling; restriction of substances; civil penalty.

AMENDMENT IN THE NATURE OF A SUBSTITUTE

—————

Patrons—Seibold, Cousins and Tran

—————

(ProposedReferred by the Houseto Committee on Health and Human Services

—————

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1 as follows:

§ 32.1-73.28:1. Menstrual supplies ingredient labeling; restriction of substances; civil penalty.

A. As used in this section:

" Confidential substance " means any element or substance that a manufacturer has added to menstrual supplies that have a functional or technical effect on the finished product , and for which a claim has been approved by the United States Environmental Protection Agency for inclusion on the confidential portion of the Toxic S ubstances Control Act Chemical Substance Inventory , as defined in ( 15 U.S.C. § 2601 et seq.), or for which the m anufacturer of the menstrual supplies or the supplier of the substance clai m s protection under the federal Defend Trade Secrets Act (18 U.S.C . § 1836 et seq.) , or products covered under the Generally Recognized as Safe designation of the United States Food and Drug Administration as provided for in 21 C.F.R . § 170.30 .

"Ingredient" means an y added substance that is present in menstrual supplies that has a functional or technical effect on the finished product, provided that the substance or the combination of substances is not considered a confidential substance .

" Intentionally added ingredient " means any element or compound that a manufacturer has added to menstrual supplies, including the components of intentionally added fragranc e, flavoring , and colorants, and the intentional breakdown products of an added element or compound that have a fu nctional or technical effect on the finished product.

"Label" means a display of written, printed, or graphic material on or affixed to athe container in which the menstrual supplies are distributed.

"Menstrual supplies" means a product for use in connection with the menstrual cycle, including tampons, pads, and menstrual cups. Such products may be either disposable or reusable.

" Package or box containing menstrual supplies " shall not include packaging used exclusively for shipping purposes.

" Per fluoroalkyl and polyfluoroalkyl substances " means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom .

" Restricted substance " means an unsafe chemical for inclusion in menstrual products as determined by the Commissioner, including lead, mercury and related compounds, formaldehyde, triclosan, toluene, talc, dibutyl phthalate, di(2 - e th ylhex yl ) phthalate, butylphenyl methylpropional , and isobutyl paraben , isopropyl paraben , butyl paraben , propylparaben, and perflu o roalkyl and polyfluoroalkyl substances .

B. Each package or box containing menstrual supplies sold within the Commonwealth shall contain a label of all ingredients that are included within such supplies , with the ingredients within the menstrual supplies listed in descending order of predominance . The label shall be displayed by the manufacturer in a manner that is visible and easy to understand for the consumer to understand . When required to make changes to the label on menstrual supplies due to an ingredient addition or removal, the manufacturer shall make th is change to the label after making any such change to the ingredient s . The provisions of this subsection shall not restrict the continued sa le of such menstrual supplies by a retailer of any existing inventory in stock before July 1, 2026.

C. The manufacturer of menstrual supplies shall post on its website the label pursuant to subsection B , and also post information re gard ing a change to the label of menstrual supplies after making any su ch change, addition, or removal. The manufacturer may use technologies including a digital link to communicate information pursuant to this section.

D . A manufacturer of menstrual supplies sold within the Commonwealth shall not be required under this section to disclose a confidential substance on a package or box or on its website. If a manufacturer declines to disclose a confidential substance on a package or box containing menstrual supplies or on its website in order to protect the identity of such a substance , the manufacturer shall include the confidential substance by its co mmon name with the label information required pursuant to subsection B.

C. M enstrual supplies distributed or sold within the Commonwealth , whether at retail, wholesale, for personal, professional , or commercial us e, or for promotional purposes, shall not contain a restricted substance :

1. A s an intentionally added ingredient at any level ; or

2 . At or above a level determined by the Department. The Department shall establish the lowest level that can be feasibly achieved by a restricted substance , provided that the Department shall review such level every five years to determine whether it should be lowered .

E . The requirements of this section shall apply in addition to any other labeling requirements established by any other provisionprovisions of law.

F. Any person who violates the requirements of this section is subject to a civil penalty not to exceed $1,000. Such civil penalty shall be collected by the Commissioner and the proceeds shall be paid into the Breast and Cervical Cancer Prevention and Treatment Fund established pursuant to § 32.1-368.

2. That, by July 1, 2027, the Board of Health shall promulgate regulations establishing the lowest level of each restricted substance that can be feasibly achieved by manufacturers of menstrual products pursuant to subsection D of § 32.1-73.28:1 of the Code of Virginia, as created by this act.

Volver al texto completo